Levels of Interleukin 6 and Tumor Necrosis Factor-α in Serum from Fibrosarcoma Induced Rats

被引:0
作者
Sacu, Dilek [2 ]
Bildik, Ayseguel [1 ]
机构
[1] Adnan Menderes Univ, Vet Fak, Biyokimya Anabilim Dali, Aydin, Turkey
[2] Aydin Goz Hastanesi, Aydin, Turkey
关键词
Fibrosarcoma; IL-6; TNF-alpha; Rat; HUMAN OVARIAN-CARCINOMA; COLORECTAL-CANCER; CELLS; CYTOKINES; IL-6;
D O I
暂无
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
Cytocines, produced by virtually all types of cells, are multifunctional polypeptide. TNF-alpha is a plethoric cytokine that has a major role in natural and acquired immune, cell regulation and differentiation and apoptosis. IL-6 has a lot of functions in natural and acquired immune, inhibit growth at carcinoma, tissue's growthing and differential. In this study, serum IL-6 and TNF-alpha levels were investigated in fibrosarcoma induced by 3-methylcholantrene. Sixteen male Spraque Dawley rats were used in this study. The experiment took about 150-210 days until the appearance of tumor tissue. 0.2mg 3-methylcholantrene solved in 0.25ml sesame oil were injected subcutaneously on the neck to experimental group, however only sesame oil given to control group. To find out whether any tumor tissue occurred animals were palpated daily. At the end of the experiment, the blood of animals was taken from atrium of the hearth under the ether anesthesia and than serum was prepared. Serum IL-6 and TNF-alpha levels were analyzed using BioSource kits at ELISA. Serum IL-6 levels were found 67.85+/-3.13 pg/ml in experimental group; 38.45+/-3.39 pg/ml in control group. It was 1.8 times higher than controls. Serum TNF-alpha levels were 53.35+/-9.08 pg/ml in experimental group; 26.42+/-2.22 pg/ml in control group. It was 2 times higher than controls. In the light of these findings it is thought that results of study are beneficial to understand pathogenesis and prognosis of cancer.
引用
收藏
页码:681 / 686
页数:6
相关论文
共 32 条
  • [1] ABBAS AK, 2000, CELLULAR MOL IMMUNOL, P235
  • [2] AKKOC A, 2005, ERISIM TARIHI
  • [3] ARDA M, 1994, IMMUNOLOJI, P179
  • [4] Ashizawa T, 2006, ACTA MED OKAYAMA, V60, P325
  • [5] Inflammatory cells, cytokines and chemokines in breast cancer progression: reciprocal tumor-microenvironment interactions
    Ben-Baruch, A
    [J]. BREAST CANCER RESEARCH, 2003, 5 (01) : 31 - 36
  • [6] COMEZ Y, 2006, THESIS UROLOJI KLINI, V1
  • [7] Interleukin-6 serum level correlates with survival in advanced gastrointestinal cancer patients but is not an independent prognostic indicator
    De Vita, F
    Romano, C
    Orditura, M
    Galizia, G
    Martinelli, E
    Lieto, E
    Catalano, G
    [J]. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2001, 21 (01) : 45 - 52
  • [8] ERER H, 2000, VET ONKOLOJI, V2, P76
  • [9] GIRI D, 2001, AM J PATHOL, V159, P6
  • [10] Grimm EA, 2000, CLIN CANCER RES, V6, P3895